Skip to main content
. Author manuscript; available in PMC: 2008 Dec 15.
Published in final edited form as: Am J Cardiol. 2007 Oct 29;100(12):1759–1766. doi: 10.1016/j.amjcard.2007.07.027

Figure 4.

Figure 4

The number of subjects with 0, 1, 2, 3, 4, or 5 of the ATPIII criteria and with ATPIII defined metabolic syndrome for Controls (panel A), Low Amount/Moderate Intensity (panel B), Low Amount/Vigorous Intensity (panel C), and High Amount/Vigorous Intensity (panel D) are shown. The percentage change in ATPIII prevalence was +19% in Controls, −44% in the Low Amount/Moderate Intensity, −12% in the Low Amount/Vigorous Intensity, and −44% in the High Amount/Vigorous Intensity groups.